different kinds of glp-1 what are the types drugs Market Overview: Agonists and Obesity Market GLP-1 agonists approved for clinical

Due to risks for decreased bioavailability of birth control pills, the manufacturer of Mounjaro (tirzepatide) recommends that patients either use barrier contraception for four weeks after initiation or dosage increase or switch to a non-oral contraceptive

Manufactured by Bio360, South Korea

With a clean setup, the right needle, a well-chosen injection site, and a slow, confident push of the plunger, home administration becomes routine

Others experience it as a loss of pleasure or mild emotional flatness around food. Trial mood scores moved slightly better rather than worse, so the negative experience appears to be a minority signal that standard adverse-event tables do not capture well

The short answer is, it depends

However, approaches vary: Some employers cover GLP-1s for diabetes only, but exclude them for weight loss unless medically necessary